Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2010
03/10/2010EP2161262A1 THCV and THCV extracts derived from plant material
03/10/2010EP2161258A2 4-oxoquinoline compound and use thereof as hiv integrase inhibitor
03/10/2010EP2161252A1 N-Alkylcarbonyl-amino acid ester and N-Alkylcarbonyl-amino lactone compounds and their use
03/10/2010EP2161024A1 Combination product for the treatment of cancer
03/10/2010EP2161023A2 Anti-angiogenic agents and methods of use.
03/10/2010EP2161022A1 Production of phosphate connectors and phosphate connectors produced according to the method
03/10/2010EP2160466A1 Treatment and prevention of influenza
03/10/2010EP2160465A1 Tumour growth inhibitory compounds and methods of their use
03/10/2010EP2160396A2 Thiocarbon-protecting groups for rna synthesis
03/10/2010EP2160394A1 Tenofovir disoproxil hemi-fumaric acid co-crystal
03/10/2010EP2160393A1 Novel compounds as cannabinoid receptor ligands
03/10/2010EP2160392A2 Novel macrocyclic inhibitors of hepatitis c virus replication
03/10/2010EP2160390A1 Novel process
03/10/2010EP2160387A2 Heteroarylamide pyrimidone compounds
03/10/2010EP2160386A1 Therapeutic ((phenyl)imidazolyl)methylquinolinyl compounds
03/10/2010EP2160385A1 2-substituted isoflavonoid compounds, medicaments and uses
03/10/2010EP2160381A2 Spirocyclic quinazoline derivatives and their use as pde7 inhibitors
03/10/2010EP2160380A1 Cyano-guanidine derivatives as glutaminyl cyclase inhibitors
03/10/2010EP2160377A1 Targeting diazo prodrugs for the treatment of gastrointestinal diseases
03/10/2010EP2160195A1 Novel muscle relaxant using negative charge gold nanoparticle with choline
03/10/2010EP2160193A1 Furanone copolymers
03/10/2010EP2160192A1 Antimicrobial materials and coatings
03/10/2010EP2160191A1 Suppression of viruses involved in respiratory infection or disease
03/10/2010EP2160190A1 5beta, 14beta-androstane derivatives useful for the treatment of restenosis after angioplastic or endoartherectomy and diseases due to organ fibrosis
03/10/2010EP2160187A1 Spiroindalones
03/10/2010EP2160186A2 Creatine compositions for skin treatment
03/10/2010EP2160184A2 Hypercompressed particles for controlled release of ophthalmic medications
03/10/2010EP2160183A1 Extended release formulations comprising quetipine and methods for their manufacture
03/10/2010EP2160182A1 Formulations and methods for treating dry eye
03/10/2010EP2029558B1 Compounds and methods for modulating fxr
03/10/2010EP2027122B1 Novel 1,4-diaza-bicyclo[3.2.2]nonane derivatives and their medical use
03/10/2010EP2013166B1 N-carbamoylmethyl-4(r)-phenyl-2-pyrrolidinone, method of its preparation and pharmaceutical use
03/10/2010EP1973425B1 Novel use of a polyamine-depleted food composition for human or veterinary use, for preparing a therapeutic food product
03/10/2010EP1951235B1 Novel crystal forms of irinotecan hydrochloride
03/10/2010EP1863818B1 Acetylenyl-pyrazolo-pvrimidine derivatives as mglur2 antagonists
03/10/2010EP1841737B1 N-(heteroaryl)-1h-indole-2-carboxamide derivatives and their use as vanilloid trpv1 receptor ligands
03/10/2010EP1841423B1 Use of 1- benzyl-1- hydroxy-2, 3-diamino-propyl amines, 3-benzyl-3-hydroxy-2-amino propionic acid amides and related compounds as analgesics
03/10/2010EP1828182B1 Therapeutic pyrazolo[3,4-b]pyridines and indazoles
03/10/2010EP1807420B1 Trisubstituted thiophenes as progesterone receptor modulators
03/10/2010EP1786801B1 2-arylcarbamoyl-indoles as cytokine inhibitors
03/10/2010EP1781296B1 Quinazoline derivatives and their use in the treatment of thrombocythemia
03/10/2010EP1765816B1 Substituted 1-propiolylpiperazines having an affinity for the mglur5 receptor in order to treat painful conditions
03/10/2010EP1751113B1 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
03/10/2010EP1745031B1 Crystalline forms of duloxetine free base
03/10/2010EP1715865B1 Hyperlipemia therapeutic agent comprising pitavastatins and eicosapentaenoic acid
03/10/2010EP1713510B1 Growth factor-binding compounds attached to a calixarene
03/10/2010EP1682541B1 Method for producing tiotropium salts
03/10/2010EP1651628B1 Antibiotic compound
03/10/2010EP1554586B1 Identification of drugs against mycobacteria
03/10/2010EP1511752B3 Camptothecins with a modified lactone ring
03/10/2010EP1460998B1 Extended release pharmaceutical tablet of metformin
03/10/2010EP1423376B1 Bicyclic compound, production and use thereof
03/10/2010EP1377293B1 Aryl and biaryl piperidines used as mch antagonists
03/10/2010EP1313699B1 5-asa derivatives having anti-inflammatory and antibiotic activity and methods of treating diseases therewith
03/10/2010EP1030663B1 Treatment of fibromyalgia and related disorders
03/10/2010EP1023315B1 Methods and compositions for destruction of selected proteins
03/10/2010EP0980363B1 Preparation of isoflavones from legumes
03/10/2010EP0932678B2 A family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof
03/10/2010EP0830146B1 Methods of inducing immune tolerance using immunotoxins
03/10/2010CN101668532A Method of treating vitamin d insufficiency and deficiency
03/10/2010CN101668531A Combination therapy for treatment of immune disorders
03/10/2010CN101668530A methods of activating irs-1 and akt
03/10/2010CN101668529A Piperazine-substituted pyridazinone derivatives useful as glucan synthase inhibitors
03/10/2010CN101668528A Compounds and methods for treatment of hcv
03/10/2010CN101668527A pharmaceutical formulation
03/10/2010CN101668526A A novel use of antidepressant compounds and related compositions
03/10/2010CN101668525A New use of glutaminyl cyclase inhibitors
03/10/2010CN101668524A Pyrazole derivatives as 11-beta-hsd1 inhibitors
03/10/2010CN101668523A An anti-diabetic extract of honeybush
03/10/2010CN101668522A Composition and method for binding acetaldehyde in stomach
03/10/2010CN101668521A New combination for use in the treatment of inflammatory disorders
03/10/2010CN101668520A Methods for the treatment of liver diseases
03/10/2010CN101664554A Combination product comprising SRC kinase inhibitor AZD0530 and an antioestrogen or EGFR-TK-inhibitor
03/10/2010CN101664418A Application of Sarcopyramis nepalensis Wall polysaccharide for preparing anti-HBV medicine
03/10/2010CN101664417A Niclofolan-contained compound sustained-release animal parasiticide
03/10/2010CN101664416A Application of astragaloside in treating delayed type hypersensitivity mediated diseases
03/10/2010CN101664415A Injection used for treating dog colibacillus infection and preparation method thereof
03/10/2010CN101664414A Combination of brimonidine and timolol for topical ophthalmic use
03/10/2010CN101664413A Medicinal health agent for preventing and treating canine/feline magnesium ammonium phosphate stones
03/10/2010CN101664412A Medicinal health agent for preventing and treating canine uric acid calculi
03/10/2010CN101664411A Solid dispersion or medicinal solid dispersion preparation of phenylalanine derivative
03/10/2010CN101664410A Medicine composition of rosiglitazone and amiloride and application thereof
03/10/2010CN101664409A Stabilization of hypoxia inducible factor (HIF) alpha
03/10/2010CN101664408A Stabilization of hypoxia inducible factor (HIF) alpha
03/10/2010CN101664407A Pharmaceutical composition for treating angiocardiopathy
03/10/2010CN101664406A Composition for treating and/or preventing gastric ulcer and use thereof
03/10/2010CN101664405A New application of albendazole
03/10/2010CN101664404A Fragrant solomonseal rhizome isoflavanone extract as well as preparation method and application thereof
03/10/2010CN101664403A Medicinal composition for treating cancer and signal transduction path thereof
03/10/2010CN101664402A Ginkgo flavone and tea polyphenol combined anti-radiation medicament
03/10/2010CN101664401A Application of usnic acid in preparation of drugs inhibiting angiogenesis
03/10/2010CN101664400A Application of salvianolic acid B to preparation of medicament for treating tumor
03/10/2010CN101664399A Application of perillene in preparing antibacterial drugs
03/10/2010CN101664398A Application of perillene in preparing drugs with function of promoting intestinal peristalsis and combination
03/10/2010CN101664397A Application of high-purity EPA-E and DHA polyenoic acid ethyl ester in preparation of nutritional supplement for patients in operative period
03/10/2010CN100593543C Hemin production process
03/10/2010CN100593539C Malonamide derivatives blocking the activtiy of gamma-secretase
03/10/2010CN100593405C External preparation of Fexofenadine
03/10/2010CN100593404C Ketorolac tromethamine freezing-dried power injection and preparation method thereof
03/10/2010CN100593403C Oxiracetam preparation and method of preparing the same